Health
Results: 1141-1152 of 7444

EQT Life Sciences Leads USD 44 Million Series B Financing in Cyted Health to Accelerate US Expansion

Polpharma Biologics and MS Pharma Sign Licensing Agreements for Proposed Vedolizumab (PB016), Ocrelizumab (PB018) and Guselkumab (PB019) Biosimilars

Brenus Pharma Announces First Patients Dosed in its First-in-Human Trial Evaluating STC-1010, a Next-Generation Immunotherapy





